Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
NCT02831231
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
xanomeline tartrate
DRUG:
Trospium chloride
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company